127 related articles for article (PubMed ID: 20484180)
1. MRI-guided region-of-interest delineation is comparable to manual delineation in dopamine transporter SPECT quantification in patients: a reproducibility study.
Ziebell M; Pinborg LH; Thomsen G; de Nijs R; Svarer C; Wagner A; Knudsen GM
J Nucl Med Technol; 2010 Jun; 38(2):61-8. PubMed ID: 20484180
[TBL] [Abstract][Full Text] [Related]
2. Validation of a method for accurate and highly reproducible quantification of brain dopamine transporter SPECT studies.
Jensen PS; Ziebell M; Skouboe G; Khalid U; de Nijs R; Thomsen G; Knudsen GM; Svarer C
J Nucl Med Technol; 2011 Dec; 39(4):271-8. PubMed ID: 22072699
[TBL] [Abstract][Full Text] [Related]
3. Extended studies of the striatal uptake of 99mTc-NC100697 in healthy volunteers.
Koch W; Pogarell O; Pöpperl G; Hornung J; Hamann C; Gildehaus FJ; Seelos K; Lewis D; Favit A; Tatsch K
J Nucl Med; 2007 Jan; 48(1):27-34. PubMed ID: 17204696
[TBL] [Abstract][Full Text] [Related]
4. Test-retest variability and reliability of 123I-IBZM SPECT measurement of striatal dopamine D2 receptor availability in healthy volunteers and influence of iterative reconstruction algorithms.
Catafau AM; Bullich S; Danús M; Penengo MM; Cot A; Abanades S; Farré M; Pavía J; Ros D
Synapse; 2008 Jan; 62(1):62-9. PubMed ID: 17960766
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the superselective radioligand [123I]PE2I for imaging of the dopamine transporter in SPECT.
Ziebell M
Dan Med Bull; 2011 May; 58(5):B4279. PubMed ID: 21535991
[TBL] [Abstract][Full Text] [Related]
6. The feasibility of using CT-guided ROI for semiquantifying striatal dopamine transporter availability in a hybrid SPECT/CT system.
Hsu CC; Chang YH; Lin WC; Tang SW; Wang PW; Huang YC; Chiu NT
ScientificWorldJournal; 2014; 2014():879497. PubMed ID: 25531005
[TBL] [Abstract][Full Text] [Related]
7. Reproducibility of [123I]PE2I binding to dopamine transporters with SPECT.
Ziebell M; Thomsen G; Knudsen GM; de Nijs R; Svarer C; Wagner A; Pinborg LH
Eur J Nucl Med Mol Imaging; 2007 Jan; 34(1):101-9. PubMed ID: 16896668
[TBL] [Abstract][Full Text] [Related]
8. Image quality and data quantification in dopamine transporter SPECT: advantage of 3-dimensional OSEM reconstruction?
Winz OH; Hellwig S; Mix M; Weber WA; Mottaghy FM; Schäfer WM; Meyer PT
Clin Nucl Med; 2012 Sep; 37(9):866-71. PubMed ID: 22889776
[TBL] [Abstract][Full Text] [Related]
9. Imaging of the striatal and extrastriatal dopamine transporter with (18)F-LBT-999: quantification, biodistribution, and radiation dosimetry in nonhuman primates.
Varrone A; Stepanov V; Nakao R; Tóth M; Gulyás B; Emond P; Deloye JB; Vercouillie J; Stabin MG; Jonsson C; Guilloteau D; Halldin C
J Nucl Med; 2011 Aug; 52(8):1313-21. PubMed ID: 21764797
[TBL] [Abstract][Full Text] [Related]
10. Delineation of target volume for radiotherapy of high-grade gliomas by 99m Tc-MIBI SPECT and MRI fusion.
Krengli M; Loi G; Sacchetti G; Manfredda I; Gambaro G; Brambilla M; Carriero A; Inglese E
Strahlenther Onkol; 2007 Dec; 183(12):689-94. PubMed ID: 18040614
[TBL] [Abstract][Full Text] [Related]
11. What is the optimal clinical technique for measurement of left ventricular volume after myocardial infarction? A comparative study of 3-dimensional echocardiography, single photon emission computed tomography, and cardiac magnetic resonance imaging.
Chan J; Jenkins C; Khafagi F; Du L; Marwick TH
J Am Soc Echocardiogr; 2006 Feb; 19(2):192-201. PubMed ID: 16455424
[TBL] [Abstract][Full Text] [Related]
12. Reduced midbrain dopamine transporter binding in male adolescents with attention-deficit/hyperactivity disorder: association between striatal dopamine markers and motor hyperactivity.
Jucaite A; Fernell E; Halldin C; Forssberg H; Farde L
Biol Psychiatry; 2005 Feb; 57(3):229-38. PubMed ID: 15691523
[TBL] [Abstract][Full Text] [Related]
13. Dopamine transporter loss visualized with FP-CIT SPECT in the differential diagnosis of dementia with Lewy bodies.
O'Brien JT; Colloby S; Fenwick J; Williams ED; Firbank M; Burn D; Aarsland D; McKeith IG
Arch Neurol; 2004 Jun; 61(6):919-25. PubMed ID: 15210531
[TBL] [Abstract][Full Text] [Related]
14. Quantification of 123I-PE2I binding to dopamine transporter with SPECT after bolus and bolus/infusion.
Pinborg LH; Ziebell M; Frøkjaer VG; de Nijs R; Svarer C; Haugbøl S; Yndgaard S; Knudsen GM
J Nucl Med; 2005 Jul; 46(7):1119-27. PubMed ID: 16000280
[TBL] [Abstract][Full Text] [Related]
15. Quantification analysis of 123I-IPT single photon emission computed tomography uptake in the striatum of parkinsonism with the standard magnetic resonance template.
Juh R; Pae CU; Lee CU; Kim J; Moon D; Suh T; Choe B
Psychiatry Clin Neurosci; 2006 Feb; 60(1):18-28. PubMed ID: 16472355
[TBL] [Abstract][Full Text] [Related]
16. Quantitative Analysis of ¹⁸F-(E)-N-(3-Iodoprop-2-Enyl)-2β-Carbofluoroethoxy-3β-(4'-Methyl-Phenyl) Nortropane Binding to the Dopamine Transporter in Parkinson Disease.
Fazio P; Svenningsson P; Forsberg A; Jönsson EG; Amini N; Nakao R; Nag S; Halldin C; Farde L; Varrone A
J Nucl Med; 2015 May; 56(5):714-20. PubMed ID: 25791993
[TBL] [Abstract][Full Text] [Related]
17. The striatal dopamine transporter in first-episode, drug-naive schizophrenic patients: evaluation by the new SPECT-ligand[99mTc]TRODAT-1.
Schmitt GJ; Meisenzahl EM; Frodl T; La Fougère C; Hahn K; Möller HJ; Dresel S
J Psychopharmacol; 2005 Sep; 19(5):488-93. PubMed ID: 16166186
[TBL] [Abstract][Full Text] [Related]
18. Improvement in the measurement error of the specific binding ratio in dopamine transporter SPECT imaging due to exclusion of the cerebrospinal fluid fraction using the threshold of voxel RI count.
Mizumura S; Nishikawa K; Murata A; Yoshimura K; Ishii N; Kokubo T; Morooka M; Kajiyama A; Terahara A
Ann Nucl Med; 2018 May; 32(4):288-296. PubMed ID: 29546633
[TBL] [Abstract][Full Text] [Related]
19. Simplified Quantification Method for In Vivo SPECT Imaging of the Vesicular Acetylcholine Transporter with 123I-Iodobenzovesamicol.
Mazère J; Mayo W; Pariscoat G; Schulz J; Allard M; Fernandez P; Lamare F
J Nucl Med; 2015 Jun; 56(6):862-8. PubMed ID: 25908834
[TBL] [Abstract][Full Text] [Related]
20. Quantification and visualization of defects of the functional dopaminergic system using an automatic algorithm.
Habraken JB; Booij J; Slomka P; Sokole EB; van Royen EA
J Nucl Med; 1999 Jul; 40(7):1091-7. PubMed ID: 10405125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
